Multiple Sclerosis Clinical Trials

Showing 4361-4380 of 5,960 trials

FREE Study - Fracture Reduction Evaluation

NCT00211211

The primary objective of this study is to compare the effectiveness of standard medical therapy alone to kyphoplasty using the KyphX system for the treatment of acute vertebral body compression fractures.

OsteopeniaOsteoporosisMultiple Myeloma+1 more

Medtronic Spine LLC300 participantsStarted Feb 2003

Birmingham, Alabama, United States

COMPLETEDPhase 1

Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer

NCT00540943

Subjects will be entered into cohorts of 3 for the dose escalation phase so that the maximum tolerated dose can be determined. 18 additional patients will be recruited once the maximum tolerated dose (MTD) is determined for disease assessment.

Neoplasms, Colorectal

GlaxoSmithKline25 participantsStarted Jul 2007

Saint-Herblain, France • Toulouse, France

TERMINATEDPhase 2

Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer

NCT00477087

The purpose of this study is to evaluate the effect of the combination of mitoxantrone and granulocyte-macrophage colony stimulating factor (GM-CSF) on progression-free survival (PFS) and overall survival (OS), in patients with hormone-refractory prostate cancer.

Prostatic Neoplasms

Stanford University10 participantsStarted Jul 2006

Stanford, California, United States

FREE Study - Fracture Reduction Evaluation

Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer

Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer

Related Searches

Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors

Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal Cancer

Spinal Anesthesia Using Lidocaine and Sufentanil and (Transient Neurological Symptoms) TNS

Evaluation of Tomosynthesis for Characterization and the Management of Breast Lesions

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

Impact of Pulmonary Follow-up After Stem Cell Graft

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer

Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.

Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)

The Mindfulness Intervention as Myocardial Infarction Rehabilitation Additive (MIMIRA) Study

To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer

Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer

Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children

A Novel Technique of HALS With CME and CVL for RCC

The Coexistence of Atherosclerotic Intracranial Arterial Stenosis With Intracranial Aneurysms